Glycan Bioscience LLC
Botanix Pharma Inc.
He has led the development of the company’s product pipeline and the creation of Churchill’s market entry strategy. Matt has more than 18 years of corporate leadership, legal, licensing and investment management experience.
Matt has worked as an investment director for two venture capital firms investing in life sciences, clean technology and other sectors. He was the founding CEO of iCeutica Inc. and co-founder of Glycan Bioscience LLC, Orthocell Ltd (ASX:OCC) and Botanix Pharma Inc.